John Colenutt
Chief Operating Officer at Genomics Plc
Profile
John Colenutt is currently the Chief Operating Officer & Director at Genomics Plc.
Previously, he held the position of Chief Operating Officer at JPMorgan Cazenove Ltd.
and Teach First.
John Colenutt active positions
Companies | Position | Start |
---|---|---|
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Chief Operating Officer | - |
Former positions of John Colenutt
Companies | Position | End |
---|---|---|
JPMorgan Cazenove Ltd.
JPMorgan Cazenove Ltd. Investment Banks/BrokersFinance J.P. Morgan Cazenove Ltd. (JPMC) is jointly owned by JPMorgan and Cazenove Group Ltd. Headquartered in London, JPMC has offices in Hong Kong, Beijing, Singapore, Frankfurt, Paris and New York as well as access to JPMorgan's global network. The firm provides a full range of investment banking services, including financial advice, M&A, investor relations, debt and equity capital markets advice and execution and equity research and distribution. The Equities business forms an important part of the Investment Banking division. JPMC analysts cover the major stocks in all areas of specialisation across the UK, Europe and Asia ex-Japan | Chief Operating Officer | - |
Teach First
Teach First Miscellaneous Commercial ServicesCommercial Services Teach First provides educational services. It works with schools and other organizations with the aim that no child’s educational success is limited by their socio-economic background. Its participants teach in schools where the majority of pupils come from the poorest families in the United Kingdom. The company was founded by Jo Owen and Brett Wigdortz in July 2002 and is headquartered in London, the United Kingdom. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Teach First
Teach First Miscellaneous Commercial ServicesCommercial Services Teach First provides educational services. It works with schools and other organizations with the aim that no child’s educational success is limited by their socio-economic background. Its participants teach in schools where the majority of pupils come from the poorest families in the United Kingdom. The company was founded by Jo Owen and Brett Wigdortz in July 2002 and is headquartered in London, the United Kingdom. | Commercial Services |
JPMorgan Cazenove Ltd.
JPMorgan Cazenove Ltd. Investment Banks/BrokersFinance J.P. Morgan Cazenove Ltd. (JPMC) is jointly owned by JPMorgan and Cazenove Group Ltd. Headquartered in London, JPMC has offices in Hong Kong, Beijing, Singapore, Frankfurt, Paris and New York as well as access to JPMorgan's global network. The firm provides a full range of investment banking services, including financial advice, M&A, investor relations, debt and equity capital markets advice and execution and equity research and distribution. The Equities business forms an important part of the Investment Banking division. JPMC analysts cover the major stocks in all areas of specialisation across the UK, Europe and Asia ex-Japan | Finance |
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- John Colenutt